Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy adults ≥ 18 years of age: A randomized, multicenter, phase II / III clinical trial
Sharma, Shrikant, Singh, Veer Bahadur, Kumar, Sanjay, Prajapati, Vipul, Patel, Jitendra, Vukkala, Rajesh, Jangid, Sanjay Kumar, Sanmukhani, Jayesh, Gupta, Gaurav, Patel, Pradip, Mittal, Ravindra, GlueLanguage:
english
Journal:
Human Vaccines & Immunotherapeutics
DOI:
10.1080/21645515.2018.1441654
Date:
February, 2018
File:
PDF, 756 KB
english, 2018